Lumbos, Marypearl .

HRN: 28=96-33  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/07/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/07/2026
05/14/2026
IV
500mg
Q8
Uti Acute Ap
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Urinary TractIntra-abdominal    Compliance to guidelines: Compliant To Guidelines